These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6489656)

  • 1. The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groups.
    Pontiroli AE; Mosca A; de Pasqua A; Alcini D; Pozza G
    Diabetologia; 1984 Aug; 27(2):235-7. PubMed ID: 6489656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
    Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator status and diabetic neuropathy.
    Shenfield GM; McCann VJ; Tjokresetio R
    Diabetologia; 1982 Jun; 22(6):441-4. PubMed ID: 7106444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylator phenotypes in diabetes mellitus.
    Stryjek-Kamińska D; Malczewski B; Kopeć A; Rowińska-Marcińska K
    Acta Diabetol Lat; 1988; 25(1):41-8. PubMed ID: 3407376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of acetylator phenotype with peripheral, autonomic and central neuropathy in Northern Indian non-insulin-dependent diabetes mellitus patients.
    Misra A; Mittal V; Jain S; Bajaj JS
    Eur J Clin Pharmacol; 1999 Aug; 55(6):419-24. PubMed ID: 10492053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between chlorpropamide-alcohol flushing and fast acetylator phenotype in type I and type II diabetes.
    Bonisolli L; Pontiroli AE; De Pasqua A; Calderara A; Maffi P; Gallus G; Radaelli G; Pozza G
    Acta Diabetol Lat; 1985; 22(4):305-15. PubMed ID: 3868908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylator phenotypes of Jordanian diabetics.
    Irshaid Y; al-Hadidi H; Abuirjeie M; Latif A; Sartawi O; Rawashdeh N
    Eur J Clin Pharmacol; 1992; 43(6):621-3. PubMed ID: 1493843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylation polymorphism and diabetes mellitus among Saudi Arabians.
    el-Yazigi A; Johansen K; Raines DA; Dossing M
    J Clin Pharmacol; 1992 Oct; 32(10):905-10. PubMed ID: 1447397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus.
    Irshaid YM; Abujbara MA; Ajlouni KM; El-Khateeb M; Jarrar YB
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of the human acetylator polymorphism in spontaneous disorders.
    Evans DA
    J Med Genet; 1984 Aug; 21(4):243-53. PubMed ID: 6387123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acetylation phenotype as a risk factor of diabetic neuropathy].
    Miarka J; Jonderko G; Straszecka J; Lachowicz B
    Przegl Lek; 1990; 47(4):385-8. PubMed ID: 2217853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of diabetes and factors associated with diabetic complications in Oneida Indians.
    Schulz LO; Lalicata M; Carnes D; Rith-Najarian SJ
    Life Sci; 1997; 60(4-5):299-306. PubMed ID: 9010485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease.
    Bodansky HJ; Drury PL; Cudworth AG; Evans DA
    Diabetes; 1981 Nov; 30(11):907-10. PubMed ID: 7297779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylation in healthy and diseased children.
    Hadasová E; Brysová V; Kadlcáková E
    Eur J Clin Pharmacol; 1990; 39(1):43-7. PubMed ID: 2276387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for micro- and macroangiopathic complications in type 2 diabetes: lack of association with acetylator phenotype, chlorpropamide alcohol flush and ABO and Rh blood groups.
    Pontiroli AE; Calderara A; Bonisolli L; De Pasqua A; Maffi P; Margonato A; Radaelli G; Gallus G; Pozza G
    Diabete Metab; 1987; 13(4):444-9. PubMed ID: 3119387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic dimorphism according to acetylator status.
    Burrows AW; Hockaday TD; Mann JI; Taylor JG
    Br Med J; 1978 Jan; 1(6107):208-10. PubMed ID: 340001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood groups and diabetes mellitus: a possible tool in the analysis of the hereditary background of diabetes mellitus.
    Kanazawa Y; Furusho T; Nakajima H; Amemiya S; Akanuma Y; Kosaka K
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():295-9. PubMed ID: 6680499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of glucose on acetylation status.
    Suhardjono D; Boutagy J; Shenfield GM
    Br J Clin Pharmacol; 1986 Oct; 22(4):401-8. PubMed ID: 3768255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.